246 related articles for article (PubMed ID: 35713822)
1. IgA vasculitis with underlying monoclonal IgA gammopathy: innovative therapeutic approach targeting plasma cells. A case series.
Hankard A; Ingen-Housz-Oro S; El Karoui K; Paule R; Lioger B; Brihaye B; Battistella M; Jobard S; Magnant J; Diot E; Bigot A; Ferreira-Maldent N; Deriaz S; Cook AR; Henique H; Maillot F; Aouba A; Audemard-Verger A;
Clin Rheumatol; 2022 Oct; 41(10):3119-3123. PubMed ID: 35713822
[TBL] [Abstract][Full Text] [Related]
2. Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone.
Kikuchi R; Onozawa M; Nagai J; Okada S; Hasegawa Y; Ohigashi H; Mitamura S; Maeda T; Takakuwa E; Fujieda Y; Goto H; Hashimoto D; Matsuno Y; Teshima T
Intern Med; 2024 Feb; 63(4):541-545. PubMed ID: 37316269
[TBL] [Abstract][Full Text] [Related]
3. Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy.
Maritati F; Canzian A; Fenaroli P; Vaglio A
Presse Med; 2020 Oct; 49(3):104035. PubMed ID: 32645417
[TBL] [Abstract][Full Text] [Related]
4. [IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review].
Adam Z; Feit J; Krejcí M; Pour L; Vasků V; Cermáková Z; Mayer J; Hájek R
Vnitr Lek; 2009 Oct; 55(10):981-90. PubMed ID: 19947244
[TBL] [Abstract][Full Text] [Related]
5. IgA pemphigus associated with monoclonal gammopathy completely resolved after achievement of complete remission of multiple myeloma with bortezomib, cyclophosphamide and dexamethasone regimen.
Adam Z; Krejcí M; Pour L; Feit J; Büchler T; Hájek R
Wien Klin Wochenschr; 2010 May; 122(9-10):311-4. PubMed ID: 20559888
[TBL] [Abstract][Full Text] [Related]
6. IgA Vasculitis in Adults: a Rare yet Challenging Disease.
Yaseen K; Herlitz LC; Villa-Forte A
Curr Rheumatol Rep; 2021 Jul; 23(7):50. PubMed ID: 34196893
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin glomerulopathy with monoclonal gammopathy responding to bortezomib plus dexamethasone: a case report.
Li X; Qi X; Ma Z; Huang W
BMC Nephrol; 2022 Nov; 23(1):382. PubMed ID: 36451151
[TBL] [Abstract][Full Text] [Related]
8. New insights on IgA vasculitis with underlying solid tumor: a nationwide French study of 30 patients.
Hankard A; Michot JM; Terrier B; Brihaye B; Chanal J; Combe C; Karras A; Urbanski G; Amoura Z; Darrigade AS; Deroux A; Guerville F; Burel LS; Maigné G; Mekinian A; Moulis G; Riviere E; Vandamme-Giard C; Maillot F; De Boysson H; Aouba A; Audemard-Verger A;
Clin Rheumatol; 2021 May; 40(5):1933-1940. PubMed ID: 33099711
[TBL] [Abstract][Full Text] [Related]
9. Rituximab treatment for IgA vasculitis: A systematic review.
Hernández-Rodríguez J; Carbonell C; Mirón-Canelo JA; Diez-Ruiz S; Marcos M; Chamorro AJ
Autoimmun Rev; 2020 Apr; 19(4):102490. PubMed ID: 32062030
[TBL] [Abstract][Full Text] [Related]
10. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
11. A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP).
Williams CEC; Lamond M; Marro J; Chetwynd AJ; Oni L
Clin Rheumatol; 2023 Dec; 42(12):3189-3200. PubMed ID: 37755547
[TBL] [Abstract][Full Text] [Related]
12. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?
Farisogullari B; Cuceoglu MK; Oral H; Yardimci GK; Bilginer Y; Ozen S; Karadag O
Intern Emerg Med; 2022 Sep; 17(6):1599-1608. PubMed ID: 35347546
[TBL] [Abstract][Full Text] [Related]
13. Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).
Maritati F; Fenoglio R; Pillebout E; Emmi G; Urban ML; Rocco R; Nicastro M; Incerti M; Goldoni M; Trivioli G; Silvestri E; Mohammad AJ; Jayne D; Eriksson P; Segelmark M; Novikov P; Harris H; Roccatello D; Vaglio A
Arthritis Rheumatol; 2018 Jan; 70(1):109-114. PubMed ID: 28973844
[TBL] [Abstract][Full Text] [Related]
14. A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.
Cai F; Phipps L; Wu P; Lin MW
Am J Case Rep; 2021 Dec; 22():e933407. PubMed ID: 34879054
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach.
Rasmussen C; Tisseyre M; Garon-Czmil J; Atzenhoffer M; Guillevin L; Salem JE; Treluyer JM; Terrier B; Chouchana L
Autoimmun Rev; 2021 Jan; 20(1):102707. PubMed ID: 33197572
[TBL] [Abstract][Full Text] [Related]
16. IgA vasculitis.
Pillebout E; Sunderkötter C
Semin Immunopathol; 2021 Oct; 43(5):729-738. PubMed ID: 34170395
[TBL] [Abstract][Full Text] [Related]
17. IgA Vasculitis: Genetics and Clinical and Therapeutic Management.
González-Gay MA; López-Mejías R; Pina T; Blanco R; Castañeda S
Curr Rheumatol Rep; 2018 Apr; 20(5):24. PubMed ID: 29611051
[TBL] [Abstract][Full Text] [Related]
18. IgA Vasculitis With Underlying Liver Cirrhosis: A French Nationwide Case Series of 20 Patients.
Elhani I; Pillebout E; Terrier B; Hankard A; Vrtovsnik F; Jourde-Chiche N; Greillier S; Groh M; Belfeki N; Bigot A; de Boysson H; Pageaux GP; Raffray L; Urbanski G; Ollivier I; Maillot F; Aouba A; Audemard-Verger A;
J Rheumatol; 2021 May; 48(5):735-740. PubMed ID: 32801133
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and Management of IgA Vasculitis (Henoch-Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey.
Audemard-Verger A; Terrier B; Dechartres A; Chanal J; Amoura Z; Le Gouellec N; Cacoub P; Jourde-Chiche N; Urbanski G; Augusto JF; Moulis G; Raffray L; Deroux A; Hummel A; Lioger B; Catroux M; Faguer S; Goutte J; Martis N; Maurier F; Rivière E; Sanges S; Baldolli A; Costedoat-Chalumeau N; Roriz M; Puéchal X; André M; Lavigne C; Bienvenu B; Mekinian A; Zagdoun E; Girard C; Bérezné A; Guillevin L; Thervet E; Pillebout E;
Arthritis Rheumatol; 2017 Sep; 69(9):1862-1870. PubMed ID: 28605168
[TBL] [Abstract][Full Text] [Related]
20. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib.
Saldanha A; Veiga ME; Okazaki E; Rothschild C; Martinez G; Rocha V; Orsi FA; Villaca P
J Thromb Thrombolysis; 2023 May; 55(4):770-774. PubMed ID: 37000318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
